Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14731-14-7

Post Buying Request

14731-14-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14731-14-7 Usage

Description

5-(Bromoacetyl)-3-phenylisoxazole is a chemical compound characterized by the molecular formula C10H8BrNO2. It is a highly reactive organic compound that features a bromoacetyl group and a phenylisoxazole ring. 5-(Bromoacetyl)-3-phenylisoxazole is recognized for its versatility in the synthesis of pharmaceuticals and agrochemicals, where it can modify and enhance the properties of certain molecules. It also serves as an intermediate in the production of various organic compounds and exhibits biological activities, making it a valuable building block in medicinal chemistry research. However, due to its reactivity, it requires careful handling to mitigate potential health and environmental risks.

Uses

Used in Pharmaceutical Synthesis:
5-(Bromoacetyl)-3-phenylisoxazole is used as a synthetic intermediate for the development of pharmaceuticals, leveraging its reactivity to modify the properties of target molecules and improve their therapeutic efficacy.
Used in Agrochemical Production:
In the agrochemical industry, 5-(Bromoacetyl)-3-phenylisoxazole is utilized as a key component in the synthesis of various agrochemicals, contributing to the enhancement of their performance and effectiveness in agricultural applications.
Used in Organic Compound Production:
5-(Bromoacetyl)-3-phenylisoxazole is employed as an intermediate in the production of a range of organic compounds, where its unique structure and reactivity are harnessed to facilitate the synthesis of complex molecules.
Used in Medicinal Chemistry Research:
5-(Bromoacetyl)-3-phenylisoxazole is used as a building block in medicinal chemistry, where its biological activities and structural features are explored for the discovery and development of new therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 14731-14-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,7,3 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 14731-14:
(7*1)+(6*4)+(5*7)+(4*3)+(3*1)+(2*1)+(1*4)=87
87 % 10 = 7
So 14731-14-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H8BrNO2/c12-7-10(14)11-6-9(13-15-11)8-4-2-1-3-5-8/h1-6H,7H2

14731-14-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-bromo-1-(3-phenyl-1,2-oxazol-5-yl)ethanone

1.2 Other means of identification

Product number -
Other names 2-bromo-1-(3-phenylisoxazol-5-yl)ethan-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14731-14-7 SDS

14731-14-7Relevant articles and documents

Synthesis and pharmacological characterization of new analogs of broxaterol

De Amici,Conti,Dallanoce,Kassi,Castellano,Stefancich,De Micheli

, p. 69 - 80 (2007/10/03)

A series of isoxazole derivatives structurally related to broxaterol 1 has been prepared and tested for their potency to β1 and β2 adrenergic receptors. At variance with broxaterol, none of the tested compounds displayed agonistic activity. The 3-isopropenyl derivative 5f is the most potent antagonist both in the trachea and atria preparations.

N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives as potent orally active antianaphylactic agents

Chiarino,Grancini,Frigeni,Biasini,Carenzi

, p. 600 - 605 (2007/10/02)

A series of N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives was synthesized and tested on the passive cutaneous anaphylaxis (PCA) model in rats to verify its potential antianaphylactic activity. These compounds were prepared by reaction of an appropri

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14731-14-7